Macquarie Group’s Opko Health OPK Stock Holding History

Macquarie Group’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-206,390	Closed	-$1.76M	–	1603
2014 Q3	$1.76M	Buy	+206,390	New	+$1.81M	﹤0.01%	1041

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group's OPK Position: Q3 2024 in Review

Macquarie Group sold out of Opko Health (OPK) in Q3 2024, closing a stake of 4,506 shares — an estimated $5.63K sold.

Macquarie Group first reported a position in OPK in Q3 2014 and held it in 14 quarters. The position peaked at $5.72M in Q1 2015. 234 funds tracked by Wall St. Rank hold OPK as of Q3 2024.

Macquarie Group reported no remaining Opko Health position as of Q3 2024 after selling out during the quarter.
Macquarie Group sold 4,506 Opko Health shares in Q3 2024, an estimated $5.63K.
Macquarie Group first reported a position in Opko Health in Q3 2014 and held it in 14 quarters.
Macquarie Group's Opko Health position peaked at $5.72M in Q1 2015.
234 funds tracked by Wall St. Rank held Opko Health as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.